sulfan blue has been researched along with Ovarian Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pyke, C | 1 |
Kollias, J; Russell, WJ | 1 |
Goins, BA; Phillips, WT; Soundararajan, A; Zavaleta, CL | 1 |
3 other study(ies) available for sulfan blue and Ovarian Neoplasms
Article | Year |
---|---|
Anaphylaxis and patent Blue V.
Topics: Anaphylaxis; Breast Neoplasms; Coloring Agents; Drug Hypersensitivity; Female; Humans; Ovarian Neoplasms; Rosaniline Dyes; Sentinel Lymph Node Biopsy | 2011 |
Anaphylaxis to patent blue dye--the benefit and the risk.
Topics: Anaphylaxis; Breast Neoplasms; Coloring Agents; Drug Hypersensitivity; Female; Humans; Melanoma; Ovarian Neoplasms; Risk Assessment; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Skin Tests | 2011 |
Use of avidin/biotin-liposome system for enhanced peritoneal drug delivery in an ovarian cancer model.
Topics: Animals; Antineoplastic Agents; Avidin; Biotin; Cell Line, Tumor; Coloring Agents; Delayed-Action Preparations; Drug Compounding; Female; Injections, Intraperitoneal; Lipids; Liposomes; Lymph Nodes; Mice; Mice, Nude; Neoplasms, Experimental; Ovarian Neoplasms; Peritoneal Cavity; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Nude; Reproducibility of Results; Rosaniline Dyes; Technetium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Transplantation, Heterologous | 2007 |